GGrantIndex
← Search

COMBINATIONAL TARGETING OF PROSTATE CARCINOMA CELLS AND TUMORS ASSOCIATED PERICYTES WITH ANTIBODY BASED IMMUNOTHERAPY AND METRONOMIC CHEMOTHERAPY

$648,552FY2008Department of DefenseDOD

University Of Pittsburgh - Of The Commonwealth System Of Higher Education

Investigators

View source on USAspending →
COMBINATIONAL TARGETING OF PROSTATE CARCINOMA CELLS AND TUMORS ASSOCIATED PERICYTES WITH ANTIBODY BASED IMMUNOTHERAPY AND METRONOMIC CHEMOTHERAPY · GrantIndex